A Pilot Study of TRV130 for the Treatment of Fracture Pain



Status:Recruiting
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:September 2015
End Date:June 2016
Contact:Trevena
Email:clinicaltrials@trevenainc.com
Phone:610-354-8840

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 2, Open-label Pilot Study of TRV130 for the Treatment of Moderate to Severe Acute Pain Associated With Long Bone Fracture

The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe
acute pain in patients presenting to the emergency department (ED) with a suspected/known,
unilateral, closed long bone fracture.

This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of
moderate to severe acute pain associated with a long bone fracture in patients presenting to
the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label
pilot study.

Inclusion Criteria:

- Age 18-65 years, inclusive

- Has a suspected/known, unilateral, closed fracture of either: radius, ulna (or both)
OR tibia, fibula (or both) BUT not fractures in more than 1 extremity

- Able to understand and comply with study procedures and requirements, and provide
written informed consent

Exclusion Criteria:

- Significant concomitant head, chest, or abdominal trauma

- Multiple extremity trauma

- Open fracture

- Clinically significant medical condition or history of such condition that may place
the patient at an unacceptable risk in the trial, may interfere with the
interpretation of efficacy, safety, or tolerability data obtained in the trial, or
may interfere with the absorption, distribution, metabolism, or excretion of drugs
We found this trial at
1
site
Trevena, Inc.
Indianapolis, Indiana
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials